Robert Hadfield

EVP, General Counsel, Secretary & Chief Compliance Officer at Alaunos Therapeutics

Robert has served as the General Counsel and Corporate Secretary since April 2018. Prior to joining Ziopharm, Rob served as Partner and General Counsel of Longwood Fund, a health care venture capital firm, from November 2017 to April 2018. He also served as General Counsel and Corporate Secretary of Flex Pharma, Inc. from April 2014 until November 2017, and was an attorney in the business department of Cooley LLP from August 2007 to August 2011 and then from April 2012 to April 2014. From August 2011 to April 2012, Rob served as Corporate Counsel at Kiva Systems, Inc., prior to its acquisition by Amazon.com, Inc. Rob began his career as a financial analyst in the health care investment banking group of SG Cowen Securities Corporation (now Cowen Inc.). He has extensive experience in the areas of corporate governance, securities law, mergers & acquisitions, intellectual property protection and compliance. Mr. Hadfield holds a B.S. degree in Finance from Providence College and a J.D. from the Georgetown University Law Center.